Antiviral effect on MS-2 coliphage obtained with a synthetic antigen.
about
The impact of new technologies on vaccine development.Viral pathogenesis and molecular biologyImmunity and protection against influenza virus by synthetic peptide corresponding to antigenic sites of hemagglutinin.Anti-influenza response achieved by immunization with a synthetic conjugate.Hepatitis B virus vaccine: identification of HBsAg/a and HBsAg/d but not HBsAg/y subtype antigenic determinants on a synthetic immunogenic peptide.Successful immunization with a totally synthetic diphtheria vaccineAntiviral response elicited by a completely synthetic antigen with built-in adjuvanticity.Both cholera toxin-induced adenylate cyclase activation and cholera toxin biological activity are inhibited by antibodies against related synthetic peptides.Antibodies against synthetic peptides of the B subunit of cholera toxin: crossreaction and neutralization of the toxin.The rational development of molecularly imprinted polymer-based sensors for protein detection.Adjuvant effect of a peptidoglycan attached covalently to a synthetic antigen provoking anti-phage antibodies.Engineered human vaccines.Antibodies against a preselected peptide recognize and neutralize foot and mouth disease virus.A poliovirus type 1 neutralization epitope is located within amino acid residues 93 to 104 of viral capsid polypeptide VP1.Structural and immunological characterization of Friend murine leukaemia virus glycopolypeptide using synthetic oligopeptides.Hedgehog and its patched-smoothened receptor complex: a novel signalling mechanism at the cell surface.The potential of retro-inverso peptides as synthetic vaccines.Characterization of an intergroup serological mutant from group II RNA phage GA.Synthetic Antigens and Vaccines
P2860
Q30411839-613CD6C4-4F9D-4226-8A8C-81769AA79F9AQ34073902-3C70E947-8D93-4025-9AFB-A23337575981Q36257657-BBF72A22-C4F9-42EE-8828-B9FA149060B4Q36278500-BF6AA213-256A-432E-AEC7-C4A741C10E2EQ36278570-05A915E2-761F-47DD-AEA6-DB0F5C79B6C9Q36308543-4AC5367F-27FC-45A7-B121-D7DD0826E256Q36416339-BE2F2DC8-43C6-4C72-ACF4-840715938BA8Q37580591-9583061A-7FEC-47E1-950B-941B2B211741Q37690884-4BAA81C1-BE5C-40AF-B208-5F7190B26CF5Q37816234-27C91617-3AAF-401B-A6AA-120DD2D403CCQ39628409-63F45012-A816-4F44-BAA3-7C8A03FECC1AQ40754536-E0FA95B2-2EED-4B4E-B8AC-ECB010AEEB2DQ41308046-9CA82921-1E25-4462-BFAC-BFABBBFE13CDQ41464907-AFDFD5A7-629E-4BF2-8076-C34D30B74082Q41578447-24345427-4A99-4ED8-A6ED-406875FE23BCQ41581685-D1CB56E2-B638-4B47-BBDD-FFE87A011965Q53852768-28248812-3CE5-4305-8067-F5FE4D2923E1Q54436206-6D35E9AA-9DC4-4282-85AF-E6BACEAD27D9Q58352976-8A817E8F-0924-48BC-B878-4168467AC1AA
P2860
Antiviral effect on MS-2 coliphage obtained with a synthetic antigen.
description
1976 nî lūn-bûn
@nan
1976 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1976 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1976年の論文
@ja
1976年論文
@yue
1976年論文
@zh-hant
1976年論文
@zh-hk
1976年論文
@zh-mo
1976年論文
@zh-tw
1976年论文
@wuu
name
Antiviral effect on MS-2 coliphage obtained with a synthetic antigen.
@en
type
label
Antiviral effect on MS-2 coliphage obtained with a synthetic antigen.
@en
prefLabel
Antiviral effect on MS-2 coliphage obtained with a synthetic antigen.
@en
P2093
P2860
P356
P1476
Antiviral effect on MS-2 coliphage obtained with a synthetic antigen.
@en
P2093
P2860
P304
P356
10.1073/PNAS.73.12.4636
P407
P577
1976-12-01T00:00:00Z